ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease - Concepedia

Concepedia

Publication | Closed Access

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

168

Citations

54

References

2021

Year

Petr Novák, Branislav Kováčech, Stanislav Katina, Reinhold Schmidt, Philip Scheltens, Eva Kontseková, Stefan Ropele, Ľubica Fialová, Milica G. Kramberger, Natalia Paulenka-Ivanovova,

Neurodegenerative DiseasesAlzheimer's DiseaseActive ImmunotherapyMedicinePathological TauImmunologyDegenerative PathologyAlzheimer ’Aging-associated DiseaseNeurodegenerationImmunotherapyNeuroimmunology

References

	Year	Citations

Page 1

Page 1